Cobra is a CDMO supporting the global life sciences industry in the development and manufacture of DNA, viral vectors and microbiota for clinical trials and commercial supply.
Over 20 years of track record in producing biologics for use in pre-clinical to Phase III clinical trials and commercial supply has given our people a unique knowledge base as both manufacturer and also as service providers for the global life sciences market.
We offer a broad range of integrated and stand-alone development services, bespoke to individual customer requirements, for the supply of investigational medicinal product for clinical trials and commercial market supply.
Every program complies with GMP standards worldwide and is conceived with an unmatched quality derived from the know-how of Cobra’s highly qualified, flexible and dedicated people. Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.